Evaluation of sudden cardiac death in hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy has become a highly manageable condition due to recent therapeutic advances that have significantly reduced its overall mortality rate. However, sudden cardiac death continues to be a critical and unsolved threat, particularly in younger patients and competitive athletes. Even after recent updates to guidelines on sudden cardiac death risk evaluation in hypertrophic cardiomyopathy, new clinical evidence continues to emerge, further enriching our understanding of risk stratification and management. In this review, we summarize current research findings and explore recent advances to provide insights into future directions in the treatment of hypertrophic cardiomyopathy.

• Publication year

  2025

• Venue

  Journal of Cardiovascular Imaging

• Publication date

  2025-10-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1186/s44348-025-00054-5PMID 41094696PMCID 12529863
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Factors associated with high-intensity physical activity and sudden cardiac death in hypertrophic cardiomyopathy

  2025cited by this paper
• The Prognostic Value of Left Ventricular Entropy From T1 Mapping in Patients With Hypertrophic Cardiomyopathy

  2024cited by this paper
• Identification and validation of ventricular rhythmic risk subgroups in hypertrophic cardiomyopathy by clustering analysis including left ventricular strain analysis

  2024cited by this paper
• 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

  2024cited by this paper
• Vigorous Exercise in Patients with Hypertrophic Cardiomyopathy: Results of the Prospective, Observational, Multinational, “Lifestyle and Exercise in HCM” (LIVE-HCM) Study

  2023cited by this paper
• Performance of 2020 AHA/ACC HCM Guidelines and Incremental Value of Myocardial Strain for Predicting SCD

  2023cited by this paper
• Integrated Sudden Cardiac Death Risk Prediction Model For Patients With Hypertrophic Cardiomyopathy.

  2023cited by this paper
• Left ventricular-global longitudinal strain as a prognosticator in hypertrophic cardiomyopathy with a low-normal left ventricular ejection fraction.

  2023cited by this paper
• Role and Clinical Importance of Progressive Changes in Echocardiographic Parameters in Predicting Outcomes in Patients With Hypertrophic Cardiomyopathy

  2023cited by this paper
• Return-to-Play for Elite Athletes With Genetic Heart Diseases Predisposing to Sudden Cardiac Death.

  2023cited by this paper
• Quantitative Late Gadolinium Enhancement Cardiac Magnetic Resonance and Sudden Death in Hypertrophic Cardiomyopathy: A Meta-Analysis.

  2023cited by this paper
• 2023 ESC Guidelines for the management of cardiomyopathies.

  2023influential reference
• Entropy of left ventricular late gadolinium enhancement and its prognostic value in hypertrophic cardiomyopathy a new CMR assessment method.

  2022cited by this paper
• Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator

  2022cited by this paper
• Translational investigation of electrophysiology in hypertrophic cardiomyopathy

  2021cited by this paper
• EVOLUTION OF RISK STRATIFICATION AND SUDDEN DEATH PREVENTION IN HYPERTROPHIC CARDIOMYOPATHY: 20 YEARS WITH THE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR.

  2021influential reference
• Clinical, echocardiographic and cardiac MRI predictors of outcomes in patients with apical hypertrophic cardiomyopathy

  2021cited by this paper
• Mean Scar Entropy by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Associated With Ventricular Arrhythmias Events in Hypertrophic Cardiomyopathy

  2021cited by this paper
• Supplementary role of left ventricular global longitudinal strain for predicting sudden cardiac death in hypertrophic cardiomyopathy.

  2021cited by this paper
• Mechanisms of Arrhythmogenicity of Hypertrophic Cardiomyopathy-Associated Troponin T (TNNT2) Variant I79N

  2021cited by this paper
• Prognostic relevance of exercise testing in hypertrophic cardiomyopathy. A systematic review

  2021cited by this paper
• Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis.

  2021cited by this paper
• Clinical outcomes in adult athletes with hypertrophic cardiomyopathy: a 7-year follow-up study

  2020cited by this paper
• Association of physical activity with all-cause and cardiovascular mortality in 7666 adults with hypertrophic cardiomyopathy (HCM): more physical activity is better

  2020cited by this paper
• Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction.

  2020cited by this paper
• Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction

  2020cited by this paper
• Genetic Basis and Molecular Biology of Cardiac Arrhythmias in Cardiomyopathies.

  2020cited by this paper
• Abnormalities in Sodium Current and Calcium Homeostasis as Drivers of Arrhythmogenesis in Hypertrophic Cardiomyopathy.

  2020cited by this paper
• N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy

  2020cited by this paper
• Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias

  2019cited by this paper
• The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast‐enhanced magnetic resonance study

  2019cited by this paper
• Prognostic Value of Global Longitudinal Strain in Hypertrophic Cardiomyopathy: A Systematic Review of Existing Literature.

  2019cited by this paper
• MRI T1 Mapping in Hypertrophic Cardiomyopathy: Evaluation in Patients Without Late Gadolinium Enhancement and Hemodynamic Obstruction.

  2019cited by this paper
• Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy.

  2019cited by this paper
• Validation of the hypertrophic cardiomyopathy risk-sudden cardiac death calculator in Asians

  2019cited by this paper
• Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy.

  2019influential reference
• Global Burden of Hypertrophic Cardiomyopathy.

  2018cited by this paper
• Altered Ca2+ and Na+ Homeostasis in Human Hypertrophic Cardiomyopathy: Implications for Arrhythmogenesis

  2018influential reference
• Histogram Analysis of Native T1 Mapping and Its Relationship to Left Ventricular Late Gadolinium Enhancement, Hypertrophy, and Segmental Myocardial Mechanics in Patients With Hypertrophic Cardiomyopathy

  2018cited by this paper
• Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events

  2018cited by this paper
• Late sodium current inhibitors to treat exercise‐induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium

  2018cited by this paper
• Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study

  2018cited by this paper
• Clinical Course and Management of Hypertrophic Cardiomyopathy

  2018cited by this paper
• Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models

  2017cited by this paper
• Comparison of Maximal Wall Thickness in Hypertrophic Cardiomyopathy Differs Between Magnetic Resonance Imaging and Transthoracic Echocardiography.

  2017cited by this paper
• Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy

  2017cited by this paper
• Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy

  2017cited by this paper
• Perspectives on the Overall Risks of Living With Hypertrophic Cardiomyopathy

  2017cited by this paper
• Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy

  2017cited by this paper
• Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management.

  2017cited by this paper
• Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals

  2017cited by this paper
• Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy

  2017cited by this paper
• Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy: A Randomized Clinical Trial

  2017cited by this paper
• International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)

  2017cited by this paper
• Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography

  2016cited by this paper
• Genotype-Dependent and -Independent Calcium Signaling Dysregulation in Human Hypertrophic Cardiomyopathy

  2016cited by this paper
• Influence of Septal Thickness on the Clinical Outcome After Alcohol Septal Alation in Hypertrophic Cardiomyopathy

  2016cited by this paper
• Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy.

  2016influential reference
• Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy

  2016cited by this paper
• Prognostic Value of LGE-CMR in HCM: A Meta-Analysis.

  2016cited by this paper
• Findings of Cardiac Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy after 16 Years

  2016cited by this paper
• Usefulness of Electrocardiographic Patterns at Presentation to Predict Long-term Risk of Cardiac Death in Patients With Hypertrophic Cardiomyopathy.

  2016cited by this paper
• How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality: Shaped by 50 Years of Clinical Research and Practice.

  2016cited by this paper
• Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.

  2015cited by this paper
• QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy

  2015cited by this paper
• A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).

  2014influential reference
• Clinical significance of left ventricular apical aneurysms in hypertrophic cardiomyopathy patients: the role of diagnostic electrocardiography.

  2014cited by this paper
• Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy

  2014cited by this paper
• Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells

  2014cited by this paper
• Phenotypic overlap in hypertrophic cardiomyopathy: apical hypertrophy, midventricular obstruction, and apical aneurysm.

  2014cited by this paper
• Clinical Phenotype and Outcome of Hypertrophic Cardiomyopathy Associated With Thin-Filament Gene Mutations

  2014cited by this paper
• Late Sodium Current Inhibition Reverses Electromechanical Dysfunction in Human Hypertrophic Cardiomyopathy

  2013cited by this paper
• A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy

  2013cited by this paper
• Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark

  2013cited by this paper
• Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: patient outcomes, rate of appropriate and inappropriate interventions, and complications.

  2013cited by this paper
• Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice

  2012cited by this paper
• Clinical and echocardiographic predictors of outcomes in patients with apical hypertrophic cardiomyopathy.

  2011cited by this paper
• Risk of sudden death in end-stage hypertrophic cardiomyopathy.

  2011cited by this paper
• Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers.

  2010cited by this paper
• Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up.

  2010cited by this paper
• Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance.

  2010cited by this paper
• Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy

  2009cited by this paper
• Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.

  2009cited by this paper
• Successful Catheter Ablation of Hemodynamically Unstable Monomorphic Ventricular Tachycardia in a Patient with Hypertrophic Cardiomyopathy and Apical Aneurysm

  2009cited by this paper
• Clinical profiles of hypertrophic cardiomyopathy with apical phenotype--comparison of pure-apical form and distal-dominant form.

  2009cited by this paper
• Sudden Deaths in Young Competitive Athletes: Analysis of 1866 Deaths in the United States, 1980–2006

  2009cited by this paper
• Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy

  2009cited by this paper
• Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.

  2008cited by this paper
• Enhanced Transmural Fiber Rotation and Connexin 43 Heterogeneity Are Associated With an Increased Upper Limit of Vulnerability in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy

  2007cited by this paper
• Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

  2007cited by this paper
• Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy

  2007cited by this paper
• Prognostic value of intra-left ventricular electromechanical asynchrony in patients with hypertrophic cardiomyopathy.

  2006cited by this paper
• Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.

  2006cited by this paper
• Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy

  2006cited by this paper
• Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.

  2005cited by this paper
• Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients.

  2005cited by this paper
• Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.

  2003cited by this paper
• Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.

  2003cited by this paper
• Familial Hypertrophic Cardiomyopathy-Linked Mutant Troponin T Causes Stress-Induced Ventricular Tachycardia and Ca2+-Dependent Action Potential Remodeling

  2003cited by this paper
• Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy.

  2001influential reference

• When Validation Reveals the Limits　- The Next Step in Sudden Death Prevention for Hypertrophic Cardiomyopathy.

  2025cites this paper